← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Rejuvenation Technologies, Inc.
Mountain View, CA
$4,466,431
Total funding
5
Grants
Funding over time
peak $3.3M · FY2020–24$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,466,431 · 5
By mechanism
R44$3,869,030 · 3
R43$324,998 · 1
R41$272,403 · 1
Investigators at Rejuvenation Technologies, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis$1,858,106
R44 · FY2024 · AA
Advanced tools for translation of intravenously-infused RNA LNP therapeutics to the clinic$1,084,194
R44 · FY2024 · TR
TERT mRNA lipid nanoparticles to extend telomeres to treat alcoholic hepatitis$626,743
R44 · FY2023 · AA
Clinically-useful vehicles for in vivo delivery of mRNA to stem and progenitor cells$324,998
R43 · FY2024 · GM
TERT mRNA lipid nanoparticles to extend telomeres to treat pulmonary fibrosis$299,987
R44 · FY2022 · HL
Preventing liver fibrosis in alcoholic hepatitis by enhancing liver regenerative capacity via transient telomere extension using lipid nanoparticle-encapsulated TERT mRNA$272,403
R41 · FY2020 · AA